These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 35867933)

  • 1. Comparing the efficacy and safety of direct oral anticoagulants versus Vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis.
    Wu X; Cao S; Yu B; He T
    Blood Coagul Fibrinolysis; 2022 Oct; 33(7):389-401. PubMed ID: 35867933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rethinking the use of direct oral anticoagulants for secondary thromboprophylaxis in patients with thrombotic antiphospholipid syndrome.
    Franco-Moreno A; Izquierdo-Martínez A; Ancos-Aracil C
    Drug Discov Ther; 2024 Sep; 18(4):213-219. PubMed ID: 39198152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct oral anticoagulants in antiphospholipid syndrome: Meta-analysis of randomized controlled trials.
    Dufrost V; Wahl D; Zuily S
    Autoimmun Rev; 2021 Jan; 20(1):102711. PubMed ID: 33197580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct oral anticoagulants in patients with antiphospholipid syndrome: a cohort study.
    Malec K; Broniatowska E; Undas A
    Lupus; 2020 Jan; 29(1):37-44. PubMed ID: 31757182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome.
    Malec K; Góralczyk T; Undas A
    Thromb Res; 2017 Apr; 152():93-97. PubMed ID: 27989533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Direct Oral Anticoagulants in Patients With Antiphospholipid Syndrome: A Systematic Review and Meta-Analysis.
    Gullapalli K; Prasad RM; Al-Abcha A; Hussain Z; Alsouqi A; Mosalem O; Hrinczenko B
    Cureus; 2022 Sep; 14(9):e29449. PubMed ID: 36299971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct oral anticoagulants versus vitamin K antagonists in antiphospholipid syndrome: A meta-analysis.
    Cerdà P; Becattini C; Iriarte A; Hernández JC; Corbella X; Riera-Mestre A
    Eur J Intern Med; 2020 Sep; 79():43-50. PubMed ID: 32482595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis.
    Dufrost V; Risse J; Reshetnyak T; Satybaldyeva M; Du Y; Yan XX; Salta S; Gerotziafas G; Jing ZC; Elalamy I; Wahl D; Zuily S
    Autoimmun Rev; 2018 Oct; 17(10):1011-1021. PubMed ID: 30103045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of direct oral anticoagulants in antiphospholipid syndrome.
    Cohen H; Efthymiou M; Isenberg DA
    J Thromb Haemost; 2018 Jun; 16(6):1028-1039. PubMed ID: 29624847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta-analysis.
    Elsebaie MAT; van Es N; Langston A; Büller HR; Gaddh M
    J Thromb Haemost; 2019 Apr; 17(4):645-656. PubMed ID: 30690830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
    Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
    Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent Thrombosis With Direct Oral Anticoagulants in Antiphospholipid Syndrome: A Systematic Literature Review and Meta-analysis.
    Sanchez-Redondo J; Espinosa G; Varillas Delgado D; Cervera R
    Clin Ther; 2019 Sep; 41(9):1839-1862. PubMed ID: 31405527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DOACs Versus VKAs in Older Adults Treated for Acute Venous Thromboembolism: Systematic Review and Meta-Analysis.
    Chaudhary R; Pagali S; Garg J; Murad MH; Wysokinski WE; McBane RD
    J Am Geriatr Soc; 2020 Sep; 68(9):2021-2026. PubMed ID: 32441334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-Analysis of Randomized Trials.
    Khairani CD; Bejjani A; Piazza G; Jimenez D; Monreal M; Chatterjee S; Pengo V; Woller SC; Cortes-Hernandez J; Connors JM; Kanthi Y; Krumholz HM; Middeldorp S; Falanga A; Cushman M; Goldhaber SZ; Garcia DA; Bikdeli B
    J Am Coll Cardiol; 2023 Jan; 81(1):16-30. PubMed ID: 36328154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct oral anticoagulants: an alternative treatment for thrombotic antiphospholipid syndrome?
    Resseguier AS; Pereira B; Rieu V; Le Guenno G; Grobost V; Ruivard M
    Lupus; 2017 Oct; 26(12):1297-1303. PubMed ID: 28355988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct Oral Anticoagulants in Antiphospholipid Syndrome-Associated Venous Thromboembolism: Real World Evidence.
    Hwang HG; Lee JH; Kim SA; Kim YK; Kim MS; Hong J; Yhim HY; Bang SM
    J Korean Med Sci; 2024 Sep; 39(36):e252. PubMed ID: 39315443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome: A Randomized Noninferiority Trial.
    Ordi-Ros J; Sáez-Comet L; Pérez-Conesa M; Vidal X; Riera-Mestre A; Castro-Salomó A; Cuquet-Pedragosa J; Ortiz-Santamaria V; Mauri-Plana M; Solé C; Cortés-Hernández J
    Ann Intern Med; 2019 Nov; 171(10):685-694. PubMed ID: 31610549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct Oral Anticoagulants for Thromboprophylaxis in Patients with Antiphospholipid Syndrome.
    Cohen H; Efthymiou M; Gates C; Isenberg D
    Semin Thromb Hemost; 2018 Jul; 44(5):427-438. PubMed ID: 28196381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature.
    Dufrost V; Risse J; Zuily S; Wahl D
    Curr Rheumatol Rep; 2016 Dec; 18(12):74. PubMed ID: 27812956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using oral anticoagulants among chronic kidney disease patients to prevent recurrent venous thromboembolism: A systematic review and meta-analysis.
    Alhousani M; Malik SU; Abu-Hashyeh A; Poznanski NJ; Al-Hasan S; Roth DF; Alsharedi M; Mustafa B
    Thromb Res; 2021 Feb; 198():103-114. PubMed ID: 33310644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.